These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 10052893

  • 1. Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results.
    King A, May J, Phillips I.
    J Antimicrob Chemother; 1998 Dec; 42(6):711-9. PubMed ID: 10052893
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of quinupristin/dalfopristin against gram-positive bacteria Haemophilus influenzae and Branhamella catarrhalis in Taiwan.
    Wang FD, Lin ML, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):433-9. PubMed ID: 10925532
    [Abstract] [Full Text] [Related]

  • 3. Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristin.
    Tenover FC, Baker CN.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():81-5. PubMed ID: 9511069
    [Abstract] [Full Text] [Related]

  • 4. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.
    Bouanchaud DH.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():15-21. PubMed ID: 9511057
    [Abstract] [Full Text] [Related]

  • 5. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
    Jorgensen JH, McElmeel ML.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():69-73. PubMed ID: 9511067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
    Lamb HM, Figgitt DP, Faulds D.
    Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF, Booker BM, Ogundele AB, Kelchin P.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media.
    Marshall SA, Kugler KC, Jones RN.
    Int J Antimicrob Agents; 2000 Aug; 15(4):291-7. PubMed ID: 10929879
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK, Fung KS, Cheng AF.
    Chemotherapy; 2001 Aug; 47(4):243-9. PubMed ID: 11399860
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.
    Finch RG.
    Drugs; 1996 Aug; 51 Suppl 1():31-7. PubMed ID: 8724814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medium and supplement effects on the antimicrobial activity of quinupristin/dalfopristin tested by agar dilution and Etest methods.
    Jones RN.
    Diagn Microbiol Infect Dis; 1996 Oct; 26(2):99-102. PubMed ID: 8985664
    [Abstract] [Full Text] [Related]

  • 18. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of quinupristin/dalfopristin against clinical isolates of common gram-positive bacteria in Taiwan.
    Chang SC, Fang CT, Hsueh PR, Luh KT, Hsieh WC.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):299-303. PubMed ID: 10212757
    [Abstract] [Full Text] [Related]

  • 20. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ, Emmanouilides C, Kroeber A, Hindler J, Bruckner DA, Territo MC, Busuttil RW.
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.